Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
Go back to Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)| (NASDAQ: LNTH) | Delayed: 109.89 +0.93 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.96 | 52 Week High | $10.70 | |||
| Open | $109.92 | 52 Week Low | $1.76 | |||
| Day High | $111.00 | P/E | N/A | |||
| Day Low | $108.00 | EPS | $0.00 | |||
| Volume | 511,117 | |||||
